NCT00960752 2021-08-13
Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
6 trialsNCT00114920 2007-02-19
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00115141 2007-02-19
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00116662 2007-02-19
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00116675 2007-02-19
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00117923 2007-02-19
Study With a Topical Gel to Treat Common Warts in Adults
Graceway Pharmaceuticals, LLC
Phase 2 Completed